# Characterization of the DELPhI System in Assessing Brain's Functionality in Different Neurological Disorders

> **NCT03832413** · — · COMPLETED · sponsor: **QuantalX Neuroscience** · enrollment: 193 (actual)

## Conditions studied

- Stroke
- TBI
- Fibromyalgia
- PDD
- Adhd
- ABD
- Ptsd
- Healthy
- MCI
- Dementia
- Cognitive Impairment
- Cognitive Decline

## Interventions

- **DIAGNOSTIC_TEST:** DELPhI (TMS-EEG analysis)

## Key facts

- **NCT ID:** NCT03832413
- **Lead sponsor:** QuantalX Neuroscience
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-23
- **Primary completion:** 2022-02-14
- **Final completion:** 2022-02-14
- **Target enrollment:** 193 (ACTUAL)
- **Last updated:** 2022-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03832413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03832413, "Characterization of the DELPhI System in Assessing Brain's Functionality in Different Neurological Disorders". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03832413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*